Synthesis and Characterization of a Three Rings Heterocyclic Spiro Furan and Evaluation of its Cytotoxicity Properties on G-292 Cell Lines

Document Type : Original Article


Department of Chemistry, Ghods City Branch, Islamic Azad University, Tehran, Iran


Synthesis and study of the medicinal properties of new spiro compounds with various functional groups is of great interest to organic and pharmaceutical researchers because of their special structure and conformation. Multi-component reactions are one of the most popular methods for synthesis of these compounds. In this study, the three-component reaction between butyl amine, dimethyl acetylene carboxylate, and 1H-indene-1,2,3-trione in toluene reflux conditions, is described. The three rings heterocyclic Spiro furan was successfully synthesized and characterized by FTIR, 1H-NMR, 13C-NMR, and Mass spectrometry. Then during the cytotoxic studies, its anticancer properties were performed on the G-292 cancer cell lines via the MTT assay and the results were reasonable.


[1] R. Pradhan, M. Patra, A.K. Behera, B.K. Mishra, R.K. Behera, Tetrahedron, 5 (2006) 779.
[2] R.R. Kumar, S. Perumal, P. Senthilkumar, P. Yogeeswari, D. Sriram, J. med. chem, 51) 2008( 5731.
[3] S.U. Maheswari, K. Balamurugan, S. Perumal, P. Yogeeswari, D. Sriram, Bioorg. med. chem. lett., 20) 2010( 7278.
[4] N. Najim, Y. Bathich, M.M. Zain, A.S. Hamzah, Z. Shaameri, Molecules, 15) 2010( 9340.
[5] K. Ding, G. Wang, J.R. Deschamps, D.A. Parrish, S. Wang, Tetrahedron lett., 46) 2005 (5949.
[6] M.A. Ali, R. Ismail, T.S. Choon, Y.K. Yoon, A.C. Wei, S. Pandian, R.S. Kumar, H. Osman, E. Manogaran, Bioorg. med. chem. lett., 20 (2010) 7064.
[7] P. Saraswat, G. Jeyabalan, M.Z. Hassan, M.U. Rahman, N.K. Nyola, Synthetic Communications, 46 (2016) 1643.
[8] K. Arya, A. Dandia, J. fluorine chem., 128 (2007) 224.
[9] T.L. Pavlovska, R.G. Redkin, V.V. Lipson, D.V. Atamanuk, Molecular diversity, 20 (2016) 299.
[10] H. Foks, D. Pancechowska-Ksepko, M. Janowiec, Z. Zwolska, E. Augustynowicz-Kopeć, Acta Pol Pharm, 61 (2004) 473.
[11] K. Bethge, H.H. Pertz, K. Rehse, An International Journal Pharmaceutical and Medicinal Chemistry, 338 (2005) 78.
[12] I. Stylianakis, A. Kolocouris, N. Kolocouris, G. Fytas, G.B. Foscolos, E. Padalko, J. Neyts, E. De Clercq, Bioorg. med. chem. lett., 13 (2003) 1699.
[13] T.P. Saragi, T. Spehr, A. Siebert, T. Fuhrmann-Lieker, J. Salbeck, Chemical Reviews, 107 (2007) 1011.
[14] S. Arab-Salmanabadi, M. Dorvar, B. Notash, Tetrahedron, 71 (2015) 1292.
[15] S. Arab-Salmanabadi, J. Heterocyclic Chem, 54 (2017) 2986.
[16] S. Arab-Salmanabadi, IJCCE, 38 (2019) 205.
[17] L. Zare Fekri, Journal of Applied Chemistry, 56 (2020) 257.
[18] A. Keivanloo, M. Gholizadeh, E. Rezaii, Journal of Applied Chemistry, 54 (2020) 71.
[19] M. Sapnakumari, B. Narayana, K. Shashidhara, B. Sarojini, Journal of Taibah University for Science, 11 (2017) 1008.
[20] H. Hosseinjani-Pirdehi, K. Rad-Moghadam, L. Youseftabar-Miri, Tetrahedron, 70 (2014) 1780.
[21] G.M. Ziarani, N. Lashgari, A.-R. Badiei, Scientia Iranica, 20 (2013) 580.
[22] T. Hayon, A. Dvilansky, O. Shpilberg, I. Nathan, Leukemia & lymphoma, 44 (2003) 1957.
[23] J. van Meerloo, G.J. Kaspers, J. Cloos, Cell Sensitivity Assays: The MTT Assay, Springer Protocols, (2011) 237.